(Q44665243)

5 December 2017

0 references

Protecting the initial site of viral entry: an alternative HIV vaccine target (English)

1 reference

5 December 2017

1

1 reference

5 December 2017

2

1 reference

5 December 2017

1 September 2011

1 reference

Expert Review of Vaccines

5 December 2017

1 reference

5 December 2017

10

1 reference

5 December 2017

9

1 reference

5 December 2017

1253-1256

1 reference

HIV-1 vaccine development after STEP.

5 December 2017

1 reference

Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection

21 January 2018

1 reference

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV

21 January 2018

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

21 January 2018

1 reference

CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects

21 January 2018

1 reference

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis

21 January 2018

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts

21 January 2018

1 reference

Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1.

21 January 2018

1 reference

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

21 January 2018

1 reference

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.

21 January 2018

1 reference

Rational antibody-based HIV-1 vaccine design: current approaches and future directions

21 January 2018

1 reference

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys

21 January 2018

1 reference

HIV infection of the genital mucosa in women.

21 January 2018

1 reference

The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.

21 January 2018

1 reference

CCR5: From Natural Resistance to a New Anti-HIV Strategy

21 January 2018

1 reference

Natural anti-CCR5 antibodies in HIV-infection and -exposure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.98

1 reference

5 December 2017

1 reference

PubMed ID

21919613